This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wallin, B. G. Articles by Aberg, H. Search for Related Content PubMed PubMed Citation Articles by Wallin, B. G. Articles by Aberg, H.

Hypertension, Vol 6, 557-562, Copyright © 1984 by American Heart Association

ARTICLES

Sympathetic outflow to muscles during treatment of hypertension with metoprolol

BG Wallin, G Sundlof, E Stromgren and H Aberg

Microelectrode recordings of multiunit sympathetic vasoconstrictor activity were made in muscle branches of the peroneal nerve in patients with essential hypertension before and during long-term treatment with the cardioselective beta-adrenergic receptor antagonist metoprolol. Nerve activity was quantified by counting the number of sympathetic bursts in the mean voltage neurogram. Metoprolol treatment lowered blood pressure and heart rate in all subjects. During long-term treatment, nerve activity was reduced both when compared to the level of activity after the first dose of the drug (p less than 0.01) and when compared to the control level before treatment (p less than 0.05). It is suggested that the reduction of sympathetic vasoconstrictor outflow to muscles contributed to the blood pressure reduction.

This article has been cited by other articles:

				S.P. Beloka, S. Gouveia, M. Gujic, R. Naeije, A.P. Rocha, and P. van de Borne Differential Effects of Oral {beta} Blockade on Cardiovascular and Sympathetic Regulation Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 323 - 331. [Abstract] [PDF]

				N. Charkoudian and J. A. Rabbitts Sympathetic Neural Mechanisms in Human Cardiovascular Health and Disease Mayo Clin. Proc., September 1, 2009; 84(9): 822 - 830. [Abstract] [Full Text] [PDF]

				J. F. R. Paton, C. J. Dickinson, and G. Mitchell Harvey Cushing and the regulation of blood pressure in giraffe, rat and man: introducing 'Cushing's mechanism' Exp Physiol, January 1, 2009; 94(1): 11 - 17. [Abstract] [Full Text] [PDF]

				M. Yoshimoto, E. A. Wehrwein, M. Novotny, G. M. Swain, D. L. Kreulen, and J. W. Osborn Effect of stellate ganglionectomy on basal cardiovascular function and responses to {beta}1-adrenoceptor blockade in the rat Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2447 - H2454. [Abstract] [Full Text] [PDF]

				A. Ciarka, B. Najem, N. Cuylits, M. Leeman, O. Xhaet, K. Narkiewicz, M. Antoine, J.-P. Degaute, and P. van de Borne Effects of Peripheral Chemoreceptors Deactivation on Sympathetic Activity in Heart Transplant Recipients Hypertension, May 1, 2005; 45(5): 894 - 900. [Abstract] [Full Text] [PDF]

				R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension Hypertension, December 1, 2004; 44(6): 847 - 852. [Abstract] [Full Text] [PDF]

				J. Burns, D. A.S.G. Mary, A. F. Mackintosh, S. G. Ball, and J. P. Greenwood Arterial Pressure Lowering Effect of Chronic Atenolol Therapy in Hypertension and Vasoconstrictor Sympathetic Drive Hypertension, October 1, 2004; 44(4): 454 - 458. [Abstract] [Full Text] [PDF]

				R. J. Huggett, E. M. Scott, S. G. Gilbey, J. B. Stoker, A. F. Mackintosh, and D. A.S.G. Mary Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension Circulation, December 23, 2003; 108(25): 3097 - 3101. [Abstract] [Full Text] [PDF]

				M. Bechir, C. Binggeli, R. Corti, R. Chenevard, L. Spieker, F. Ruschitzka, T. F. Luscher, and G. Noll Dysfunctional Baroreflex Regulation of Sympathetic Nerve Activity in Patients With Vasovagal Syncope Circulation, April 1, 2003; 107(12): 1620 - 1625. [Abstract] [Full Text] [PDF]

				M. Hausberg, M. Kosch, P. Harmelink, M. Barenbrock, H. Hohage, K. Kisters, K. H. Dietl, and K. H. Rahn Sympathetic Nerve Activity in End-Stage Renal Disease Circulation, October 8, 2002; 106(15): 1974 - 1979. [Abstract] [Full Text] [PDF]

				L. N. Graham, P. A. Smith, J. B. Stoker, A. F. Mackintosh, and D. A.S.G. Mary Time Course of Sympathetic Neural Hyperactivity After Uncomplicated Acute Myocardial Infarction Circulation, August 13, 2002; 106(7): 793 - 797. [Abstract] [Full Text] [PDF]

				J. P. Greenwood, E. M. Scott, J. B. Stoker, and D. A. S. G. Mary Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1711 - 1717. [Abstract] [Full Text] [PDF]

				T. Kubo, E. R. Azevedo, G. E. Newton, J. D. Parker, and J. S. Floras Lack of evidence for peripheral alpha1- adrenoceptor blockade during long-term treatment of heart failure with carvedilol J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1463 - 1469. [Abstract] [Full Text] [PDF]

				S. N. Hunyor, R. J. Henderson, S. K. L. Lal, N. L. Carter, H. Kobler, M. Jones, R. W. Bartrop, A. Craig, and A. S. Mihailidou Placebo-Controlled Biofeedback Blood Pressure Effect in Hypertensive Humans Hypertension, June 1, 1997; 29(6): 1225 - 1231. [Abstract] [Full Text]

				G. E. Newton and J. D. Parker Acute Effects of ß1-Selective and Nonselective ß-Adrenergic Receptor Blockade on Cardiac Sympathetic Activity in Congestive Heart Failure Circulation, August 1, 1996; 94(3): 353 - 358. [Abstract] [Full Text]